Finance

Lists
Why is APLLTD down ၄.၀၅%?
Dive Deeper
APLLTD:NSE
Alembic Pharmaceuticals Ltd
၈၀၀.၀၀ ₹
-၄.၀၅%
(-၃၃.၈၀) 1D
အောက် ၈, GMT+၅:၃၀ ၁၅:၃၀:၀၁  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for APLLTD...
Open
၈၃၃.၈၀ ₹
High
၈၃၅.၁၀ ₹
Low
၇၉၇.၉၅ ₹
Mkt. cap
ဋေ ၁.၅၄ သ
Avg. vol.
၂.၀၇ သိန်း
Volume
၁.၇၂ သိန်း
Dividend
၁.၅၀%
Quarterly dividend
၃.၀၀ ₹
Ex-dividend date
၂၀၂၆ ဇူ ၂၉
P/E ratio
၂၂.၆၈
52-wk high
၉၉၈.၀၀ ₹
52-wk low
၆၃၅.၈၀ ₹
EPS
၃၅.၂၇ ₹
Shares outstanding
၁၈.၈၅ ကုဋေ
No. of employees
၂ သောင်း
Open
၈၃၃.၈၀ ₹
High
၈၃၅.၁၀ ₹
Low
၇၉၇.၉၅ ₹
Mkt. cap
ဋေ ၁.၅၄ သ
Avg. vol.
၂.၀၇ သိန်း
Volume
၁.၇၂ သိန်း
Dividend
၁.၅၀%
Quarterly dividend
၃.၀၀ ₹
Ex-dividend date
၂၀၂၆ ဇူ ၂၉
P/E ratio
၂၂.၆၈
52-wk high
၉၉၈.၀၀ ₹
52-wk low
၆၃၅.၈၀ ₹
EPS
၃၅.၂၇ ₹
Shares outstanding
၁၈.၈၅ ကုဋေ
No. of employees
၂ သောင်း
News stories
From web sources and news partners
GlobeNewswire
GlobeNewswire
·
ပြီးခဲ့သည့် ၁၀ မိနစ်
ONAR Advances Nasdaq Listing Preparation Following Advertise Purple Acquisition and Financing
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၁၅ မိနစ်
Applied Materials (AMAT) Deepens AI Chipmaking R And D With Major Foundry Partner
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၁၀ မိနစ်
UMeWorld Upgrades to OTCQB Venture Market; Engages ARC Group Securities for Proposed Nasdaq Uplisting
Bloomberg.com
Bloomberg.com
·
ပြီးခဲ့သည့် ၂ နာရီ
AI Bubble Risks Worst S&P 500 Crash Since 2008, Strategist Says
About Alembic Pharmaceuticals Ltd
CEO-
Employees၁.၇၂ သောင်း
Founded၁၉၀၇
Headquarters-
Sector-
Website-
Last report
၂၀၂၆ ဩ ၄
Fiscal period
Q1 2027
၈.၈၀ ₹ / ၇.၇၉ ₹
+၁၃.၀၀%beat
Revenue / Est. (INR)
ဋေ ၂.၁၅ ထ / ဋေ ၁.၉၀ ထ
+၁၃.၃၄%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၁.၉၁ ထ
ဋေ ၁.၈၈ ထ
ဋေ ၁.၈၅ ထ
ဋေ ၂.၁၅ ထ
Cost of goods sold
၅၁၅.၉၂ ဋေ
၅၂၈.၉၇ ဋေ
၆၂၆.၆၃ ဋေ
၆၂၀.၀၈ ဋေ
Cost of revenue
၅၁၅.၉၂ ဋေ
၅၂၈.၉၇ ဋေ
၆၂၆.၆၃ ဋေ
၆၂၀.၀၈ ဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၄၃၇.၅၄ ဋေ
၄၃၂.၇၁ ဋေ
၄၃၈.၉၁ ဋေ
၄၇၃.၉၄ ဋေ
Operating expense
ဋေ ၁.၁၅ ထ
ဋေ ၁.၁၃ ထ
ဋေ ၁.၀၈ ထ
ဋေ ၁.၃၀ ထ
Total operating expenses
ဋေ ၁.၆၇ ထ
ဋေ ၁.၆၆ ထ
ဋေ ၁.၇၁ ထ
ဋေ ၁.၉၂ ထ
Operating income
၂၃၉.၆၂ ဋေ
၂၁၃.၃၈ ဋေ
၁၃၆.၄၅ ဋေ
၂၃၄.၁၅ ဋေ
Other non operating income
၆.၉၀ ကုဋေ
၁၅.၄၉ ကုဋေ
-၂၈.၅၆ ကုဋေ
၁၄.၉၃ ကုဋေ
EBT including unusual items
၂၂၃.၇၁ ဋေ
၁၆၁.၄၉ ဋေ
၁၁၈.၆၃ ဋေ
၂၂၁.၈၆ ဋေ
EBT excluding unusual items
၂၂၃.၇၁ ဋေ
၂၀၃.၇၂ ဋေ
၁၃၇.၄၆ ဋေ
၂၂၁.၈၆ ဋေ
Income tax expense
၄၀.၀၀ ကုဋေ
၂၉.၅၄ ကုဋေ
-၈၂.၉၀ ကုဋေ
၄၉.၅၀ ကုဋေ
Effective tax rate
၁၇.၈၈%
၁၈.၂၉%
-၆၉.၈၈%
၂၂.၃၁%
Other operating expenses
၆၄၁.၀၀ ဋေ
၆၂၁.၁၃ ဋေ
၅၅၆.၁၅ ဋေ
၇၂၃.၈၉ ဋေ
Net income
၁၈၄.၇၁ ဋေ
၁၃၂.၉၇ ဋေ
၂၀၂.၇၀ ဋေ
၁၇၃.၀၇ ဋေ
Net profit margin
၉.၆၇%
၇.၀၉%
၁၀.၉၇%
၈.၀၅%
Earnings per share
၉.၄၀
၈.၅၁
၁၁.၅၇
၈.၈၀
Interest and investment income
-
-
၈.၆၀ သန်း
-
Interest expense
-၂၄.၂၃ ကုဋေ
-၂၃.၃၁ ကုဋေ
-၂၂.၅၆ ကုဋေ
-၂၇.၆၁ ကုဋေ
Net interest expenses
-၂၄.၂၃ ကုဋေ
-၂၃.၃၁ ကုဋေ
-၂၁.၇၀ ကုဋေ
-၂၇.၆၁ ကုဋေ
Depreciation and amortization charges
၇၆.၀၇ ကုဋေ
၈၀.၁၂ ကုဋေ
၈၈.၅၉ ကုဋေ
၉၇.၇၁ ကုဋေ
EBITDA
၃၁၄.၅၄ ဋေ
၂၇၈.၂၁ ဋေ
၂၁၁.၆၄ ဋေ
၃၀၉.၃၄ ဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ